icd 9 code for hemolytic anemia

by Dolly Weissnat Published 2 years ago Updated 1 year ago 10 min read

283.9

What are the signs and symptoms of hemolytic anemia?

Hemolytic anemia due to unspecified chronic inflammatory disease. ICD-9-CM codes are used in medical billing and coding to describe diseases, injuries, symptoms and conditions. ICD-9-CM 283.0 is one of thousands of ICD-9-CM codes used in healthcare.

Which are genetic disorders cause hemolytic anemia?

283.9 is a legacy non-billable code used to specify a medical diagnosis of acquired hemolytic anemia, unspecified. This code was replaced on September 30, 2015 by …

What is an example of hemolytic anemia?

ICD-9-CM Diagnosis Codes 282.*. : Hereditary hemolytic anemias. A congenital hemolytic anemia caused by defects of the erythrocyte membrane, enzyme deficiencies, or hemoglobinopathies. A familial congenital hemolytic anemia characterized by numerous abnormally shaped erythrocytes which are generally spheroidal.

What are the symptoms of autoimmune hemolytic anemia?

282.9 is a legacy non-billable code used to specify a medical diagnosis of hereditary hemolytic anemia, unspecified. This code was replaced on September 30, 2015 by …

What is the ICD 10 code for hemolytic anemia?

A: ICD-10-CM code category D59. - (acquired hemolytic anemia) includes codes for hemolytic anemia from acquired conditions that result in the premature destruction of red blood cells, as opposed to hereditary disorders causing anemia.Oct 30, 2020

How are hemolytic anemias classified?

Hemolytic anemia is classified as normocytic anemia with an MCV of 80 to 100 fL. It is a form of low hemoglobin due to the destruction of red blood cells, increased hemoglobin catabolism, decreased levels of hemoglobin, and an increase in efforts of bone marrow to regenerate products.Jul 27, 2021

What is the other name of hemolytic anemia?

Alloimmune hemolytic anemia. Autoimmune hemolytic anemia (AIHA) Drug-induced hemolytic anemia. Glucose-6-phosphate dehydrogenase (G6PD) deficiency.

What is the ICD 10 code for autoimmune hemolytic anemia?

Other autoimmune hemolytic anemia

D59. 19 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D59. 19 became effective on October 1, 2021.

Which anemias are hemolytic anemia?

Types of hemolytic anemia

sickle cell disease.
thalassemia.
red cell membrane disorders, such as hereditary spherocytosis, hereditary elliptocytosis and hereditary pyropoikliocytosis, hereditary stomatocytosis and hereditary xeocytosis.
pyruvate kinase deficiency (PKD)
glucose-6-phosphate dehydrogenase (G6PD) deficiency.

What are the 3 types of hemolysis?

Types

Alpha-hemolysis.
Beta-hemolysis.
Gamma-hemolysis.

What labs indicate hemolytic anemia?

A standard workup for hemolysis includes lactate dehydrogenase (LDH), unconjugated bilirubin, and haptoglobin tests, as well as a reticulocyte count. Hemolysis is confirmed by increases in the reticulocyte count, LDH, and unconjugated bilirubin, along with decreased haptoglobin.

Is hemolytic anemia Microcytic or Macrocytic?

Hemolytic anemia is defined by the premature destruction of red blood cells, and can be chronic or life-threatening. It should be part of the differential diagnosis for any normocytic or macrocytic anemia. Hemolysis may occur intravascularly, extravascularly in the reticuloendothelial system, or both.Sep 15, 2018

What is the difference between hemolytic anemia and anemia?

Anemia is a condition in which the body does not have enough healthy red blood cells. Red blood cells provide oxygen to body tissues. Normally, red blood cells last for about 120 days in the body. In hemolytic anemia, red blood cells in the blood are destroyed earlier than normal.

How do you code hemolytic anemia?

Acquired hemolytic anemia, unspecified

D59. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2022 edition of ICD-10-CM D59. 9 became effective on October 1, 2021.
This is the American ICD-10-CM version of D59. 9 - other international versions of ICD-10 D59.

What is AIHA in medical terms?

Autoimmune hemolytic anemia (AIHA) is a rare immune disorder. It happens when your body mistakes red blood cells as foreign substances and attacks them. Treatments include medication, surgery or, in rare cases, a blood transfusion.Jan 31, 2022

What is warm autoimmune hemolytic anemia?

Warm autoimmune hemolytic anemia (WAHA) is an autoimmune disorder characterized by the premature destruction of healthy red blood cells (hemolysis). Autoimmune diseases occur when one's own immune system attacks healthy tissue.

Not Valid for Submission

282.9 is a legacy non-billable code used to specify a medical diagnosis of hereditary hemolytic anemia, unspecified. This code was replaced on September 30, 2015 by its ICD-10 equivalent.

Convert 282.9 to ICD-10

The following crosswalk between ICD-9 to ICD-10 is based based on the General Equivalence Mappings (GEMS) information:

Information for Medical Professionals

References found for the code 282.9 in the Index of Diseases and Injuries:

Information for Patients

If you have anemia, your blood does not carry enough oxygen to the rest of your body. The most common cause of anemia is not having enough iron. Your body needs iron to make hemoglobin. Hemoglobin is an iron-rich protein that gives the red color to blood. It carries oxygen from the lungs to the rest of the body.

ICD-9 Footnotes

General Equivalence Map Definitions#N#The ICD-9 and ICD-10 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.

Oncology, solid tumor cancer diagnoses

195.2 Abdominal cavity#N#173.5 Abdominal wall (skin)#N#154.3 Anus (anal)#N#156.9 Biliary tract (cholangiocarcinoma), unspecified site#N#188.9 Bladder, unspecified site#N#233.7 Bladder, in situ#N#191.9 Brain, unspecified site#N#174.9 Breast, female, unspecified site#N#233.0 Breast, in situ (DCIS)#N#175.9 Breast, male, unspecified site#N#162.9 Bronchus, unspecified site#N#180.9 Cervix (cervival), unspecified site#N#233.1 Cervix uteri, in situ#N#170.9 Chondrosarcoma#N#153.9 Colon (colorectal), unspecified site#N#182.0 Endometrium (endometrial)#N#150.9 Esophagus (esophageal), unspecified site#N#170.9 Ewing's sarcoma#N#159.9 Gastrointestinal tract, unspecified site#N#184.9 Genital, female, unspecified site#N#187.9 Genital, male, unspecified site#N#153.9 Intestine (bowel), large, unspecified site#N#152.9 Intestine (bowel), small, unspecified site#N#176.9 Kaposi's Sarcoma, unspecified site#N#189.0 Kidney (renal)#N#155.0 Liver (hepatocellular), primary#N#155.2 Liver, not specified as primary or secondary#N#162.9 Lung (adenocarcinoma/squamous cell carcinoma), unspecified site#N#209.36 Merkel cell carcinoma#N#145.9 Mouth, unspecified site#N#147.9 Nasopharynx, unspecified site#N#170.9 Osteosarcoma#N#183.0 Ovary (ovarian)#N#157.9 Pancreas (pancreatic), unspecified part#N#163.8 Pleura/contiguous sites#N#185 Prostate#N#233.4 Prostate, in situ#N#154.1 Rectum#N#158.0 Retroperitoneum#N#171.9 Rhabdosarcoma#N#142.9 Salivary gland, unspecified site#N#171.9 Sarcoma, connective or soft tissue#N#172.9 Skin, melanoma, unspecified site#N#173.9 Skin, unspecified malignancy, unspecified site#N#151.9 Stomach, unspecified site#N#186.9 Testis (testicular), unspecified site#N#195.1 Thorax#N#193 Thyroid#N#141.9 Tongue, unspecified site#N#199.1 Unknown primary#N#179 Uterus (uterine), unspecified site.

Oncology, hematologic diagnoses

207.00 Acute erythremia & erythroleukemia#N#207.00 Acute lymphoid leukemia (ALL)#N#206.00 Acute monocytic leukemia#N#205.00 Acyte myeloid leukemia (AML)#N#208.00 Acute leukemia, unspecified#N#277.30 E85.9 Amyloidosis#N#208.10 Chronic leukemia, unspecified#N#204.10 Chronic lymphoid leukemia (CLL)#N#206.10 Chronic monocytic leukemia#N#205.10 Chronic myeloid leukemia (CML)#N#202.40 Hairy cell leukemia#N#207.20 Megakaryocytic leukemia#N#273.1 D47.2 Monoclonal gammopathy of undetermined significance (MGUS)#N#203.00 C90.0 [0-2] Multiple myeloma (MM)#N#203.10 C90.1 [0-2] Plasma cell leukemia.

Chemotherapy-related

284.11 Antineoplastic chemotherapy induced pancytopenia#N#285.3 Antineoplastic chemotherapy induced anemia#N#995.29 Complication of chemotherapy#N#999.81 Extravasation of vesicant chemotherapy#N#V07.39 Need for other prophylactic chemotherapy#N#V58.11 Encounter for antineoplastic chemotherapy#N#V66.2 Convalescence following chemotherapy#N#V67.2 Follow-up examination following chemotherapy#N#V87.41 Personal history of antineoplastic chemotherapy.